Back to results
US 2026/0130939 A1Published application
Production and use of natural killer (nk) cell-derived extracellular vesicles for treatment of cancer and infectious disease
AssigneesSaint Louis University, The United States Government as represented by the Department of Veterans Affairs
InventorJacki KORNBLUTH
Life of this patent
Estimating the term…
Abstract
Disclosed are therapeutic compositions, methods of preparing, and methods use for the treatment of infectious diseases and cancer. More specifically. Natural Killer Cell (NK Cell)-derived extracellular vesicles (EV's) are demonstrated as potent therapeutic agents that can kill tumor cells in vivo, but do not kill normal cells.
Claims22
A method of preparing an NK cell exosome composition comprising:
- (a) culturing an NK cell is the presence of IL-2, followed by PMA;
- and
- (b) collecting the exosomes produced by the NK cell of step (a) using centrifugation followed by precipitation.
Dependencies are inferred from the claim text.